- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00538252
Parental Involvement and Children's Extra-Familial Contexts
December 10, 2013 updated by: Daniel Shaw, University of Pittsburgh
Parental Involvement, Extra-Familial Contexts and Prevention of Drug Use Risk
Parental involvement has been shown to be a robust predictor of child conduct problems (CP) and drug use risk in childhood and adolescence, but relatively little attention has been paid to the role of parental involvement in relation to child problem behavior during the transition to school-age, when children are spending more time in school, after-care settings, and in the neighborhood.
Concomitantly, as children transition from preschool to school-age, there is evidence to suggest that the quality and organization of schools, after-school care, and neighborhoods play an increasingly important role in the emergence of children's CP and drug use risk.
Specifically, we will address: 1) the extent to which the quality of school environments, after-school care, and neighborhoods are associated with the emergence of CP during the early school-age period; 2) how parental involvement in the toddler and preschool period may be associated with parental involvement and monitoring in extra-familial contexts in the early school-age years; 3) how parental involvement in schools, after-care, and the neighborhood, may moderate relationships between extra-familial factors and children's CP; and 4) whether a parenting intervention can increase parental involvement in school, after-care, and neighborhood contexts and decrease risk of children's subsequent CP.
These issues will be tested with an existing sample of 731 ethnically-diverse children from urban, suburban, and rural sites.
As all families in the study were recruited based on the presence of sociodemographic, family, and child risk factors, the cohort of children are at high risk for displaying a persistent trajectory of clinically-meaningful CP and drug use risk.
Thus, the study has the potential to fill a much-needed void on associations between extra-familial contexts and risk for early-starting CP and later problem behavior during the early school-age years.
Equally critical, the study can provide data on the potential moderating influence of involved parenting, its malleability for families facing multiple adversities, and whether family-based interventions can make a difference for children facing multiple adversities.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
731
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15260
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 3 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
731 toddlers and their families followed from age 2 to 9 recruited on the basis of low socioeconomic status, and the presence of family (e.g., parental depression, drug use) and child (disruptive behavior) risk.
Description
Inclusion Criteria:
- Previously enrolled sample of 731 children recruited on the basis of prior screening for socioeconomic, family, and child risk factors at age 2
Exclusion Criteria:
- All children and families needed to have a child 2-3 years of age with multiple socioeconomic, family, and child risk factors.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Achenbach Teacher Report Form
Time Frame: collected annually when children are ages 7 to 9 years old
|
Teachers reports on over 100 items covering children's externalizing and internalizing problem behavior
|
collected annually when children are ages 7 to 9 years old
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental Monitoring Inventory
Time Frame: Collected annually when children are ages 7 to 9
|
Both children and parents report on the amount and quality of monitoring parents provide regarding their children's after-school activities
|
Collected annually when children are ages 7 to 9
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel S. Shaw, Ph.D., University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
October 1, 2007
First Submitted That Met QC Criteria
October 1, 2007
First Posted (Estimate)
October 2, 2007
Study Record Updates
Last Update Posted (Estimate)
December 11, 2013
Last Update Submitted That Met QC Criteria
December 10, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- involvementincontext
- R01DA023245 (U.S. NIH Grant/Contract)
- DA023245
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention of Drug Abuse Risk
-
American Institutes for ResearchCompletedSmoking Tobacco | Prevention of Drug Abuse and Dependency | Alcohol Abuse and Dependency | High Risk Sex Behavior | School FailureUnited States
-
University of FloridaJohns Hopkins University; National Institutes of Health (NIH)CompletedYouths At-risk for Drug Use/AbuseUnited States
-
The Hong Kong Polytechnic UniversityRecruiting
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedDrug Abuse PreventionUnited States
-
Johns Hopkins Bloomberg School of Public HealthUniversity of Massachusetts, Lowell; Barry UniversityCompletedChild Sexual Abuse | Program Evaluation | Perpetration of Child Sexual Abuse | Prevention InterventionUnited States
-
University Medical Centre LjubljanaNational Institute of Public Health, SloveniaEnrolling by invitationDrug Abuse in Pregnancy | Microbiome Analysis | Alcohol Abuse in Pregnancy | Health Behavior, RiskySlovenia
-
Stuart WillickSports Medicine Research and Testing Laboratory; Partnership for Clean CompetitionCompletedSports Drug Abuse | Abuse of Steroids or HormonesUnited States
-
Henan Cancer HospitalWest China HospitalRecruitingPrimary/Secondary Prevention | High Risk for Febrile Neutropenia of Chemotherapy Regimens | Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile NeutropeniaChina
-
Universität des SaarlandesCompletedPrimary Prevention, Cardiovascular Risk Factor Management, Size of Response to TrainingGermany
-
University of MiamiNational Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Substance Abuse | DelinquencyUnited States